Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

202

Participants

Timeline

Start Date

April 24, 2019

Primary Completion Date

June 24, 2026

Study Completion Date

December 24, 2026

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG

Nab-paclitaxel and Cisplatin

Nab-paclitaxel,125mg/m(2), d1,d8, Cisplatin,75mg/m(2), d1, 3 week, 2 cycles.

PROCEDURE

surgery

Trial Locations (1)

RECRUITING

Jun Feng Liu, Shijiazhuang

All Listed Sponsors

lead

Hebei Medical University Fourth Hospital

OTHER